메뉴 건너뛰기




Volumn 7, Issue , 2009, Pages

Acute myocardial infarction and pulmonary embolism in a young man with pernicious anemia-induced severe hyperhomocysteinemia

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; CYANOCOBALAMIN; EPLERENONE; HEPARIN; HOMOCYSTEINE; INTRINSIC FACTOR ANTIBODY; LACTATE DEHYDROGENASE; LISINOPRIL; METOPROLOL; UNCLASSIFIED DRUG; WARFARIN;

EID: 66949152936     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-7-5     Document Type: Article
Times cited : (17)

References (21)
  • 1
    • 0026633925 scopus 로고
    • Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
    • 10.1146/annurev.nu.12.070192.001431 1503807
    • Kang S Wong P Malinow M Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease Annu Rev Nutr 1992, 12:279-98. 10.1146/ annurev.nu.12.070192.001431 1503807
    • (1992) Annu Rev Nutr , vol.12 , pp. 279-298
    • Kang, S.1    Wong, P.2    Malinow, M.3
  • 2
    • 0032499024 scopus 로고    scopus 로고
    • Homocysteine and atherothrombosis
    • 50 10.1056/NEJM199804093381507 9535670
    • Welch G Loscalzo J Homocysteine and atherothrombosis N Engl J Med 1998, 338(15):1042-50. 10.1056/NEJM199804093381507 9535670
    • (1998) N Engl J Med , vol.338 , Issue.15 , pp. 1042-1050
    • Welch, G.1    Loscalzo, J.2
  • 3
    • 0029066299 scopus 로고
    • A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
    • 10.1001/jama.274.13.1049 7563456
    • Boushey CJ Beresford SA Omenn Motulsky AG A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 1995, 274(13):1049-57. 10.1001/jama.274.13.1049 7563456
    • (1995) JAMA , vol.274 , Issue.13 , pp. 1049-1057
    • Boushey, C.J.1    Beresford, S.A.2    Omenn3    Motulsky, A.G.4
  • 4
    • 0037164375 scopus 로고    scopus 로고
    • Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis
    • 135491 12446535 10.1136/bmj.325.7374.1202
    • Wald D Law M Morris J Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis BMJ 2002, 325(7374):1202 135491. 12446535 10.1136/bmj.325.7374.1202
    • (2002) BMJ , vol.325 , pp. 1202
    • Wald, D.1    Law, M.2    Morris, J.3
  • 5
    • 0037164104 scopus 로고    scopus 로고
    • Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
    • Homocysteine Studies Collaboration 10.1001/jama.288.16.2015 12387654
    • Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis JAMA 2002, 288:2015-2022. 10.1001/jama.288.16.2015 12387654
    • (2002) JAMA , vol.288 , pp. 2015-2022
  • 6
    • 33845503323 scopus 로고    scopus 로고
    • Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of rendomized controlled trials
    • Erratum in: JAMA. 2007 Mar 7;297(9):952
    • Bazzano LA Reynolds K Holder KN He J Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of rendomized controlled trials JAMA 2006, 296(22):2720-6. Erratum in: JAMA. 2007 Mar 7;297(9):952
    • (2006) JAMA , vol.296 , Issue.22 , pp. 2720-2726
    • Bazzano, L.A.1    Reynolds, K.2    Holder, K.N.3    He, J.4
  • 7
    • 33645753544 scopus 로고    scopus 로고
    • Homocysteine lowering with folic acid and B vitamins in vascular disease
    • The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators 10.1056/ NEJMoa060900 16531613
    • The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 2006, 354:1567-1577. 10.1056/NEJMoa060900 16531613
    • (2006) N Engl J Med , vol.354 , pp. 1567-1577
  • 8
    • 1342309318 scopus 로고    scopus 로고
    • Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial
    • 10.1001/jama.291.5.565 10.1001/jama.291.5.565 14762035
    • Toole J Malinow M Chambless L et al Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 2004, 291:565-575. 10.1001/ jama.291.5.565 14762035
    • (2004) JAMA , vol.291 , pp. 565-575
    • Toole, J.1    Malinow, M.2    Chambless, L.3
  • 9
    • 33645796222 scopus 로고    scopus 로고
    • Homocysteine lowering and cardiovascular events after acute myocardial infarction
    • 10.1056/NEJMoa055227 16531614
    • Bønaa K Njølstad I Ueland P et al Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 2006, 354:1578-1588. 10.1056/NEJMoa055227 16531614
    • (2006) N Engl J Med , vol.354 , pp. 1578-1588
    • Bønaa, K.1    Njølstad, I.2    Ueland, P.3
  • 10
    • 33645777279 scopus 로고    scopus 로고
    • Homocysteine trials - Clear Outcomes for Complex reasons
    • 10.1056/NEJMe068060 16531615
    • Joseph Loscalzo Homocysteine trials - Clear Outcomes for Complex reasons N Engl J Med 2006, 354(15):1629-32. 10.1056/NEJMe068060 16531615
    • (2006) N Engl J Med , vol.354 , Issue.15 , pp. 1629-1632
    • Loscalzo, J.1
  • 11
    • 0014545138 scopus 로고
    • Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
    • 2013581 5792556
    • McCully K Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis Am J Pathol 1969, 56:111-28. 2013581 5792556
    • (1969) Am J Pathol , vol.56 , pp. 111-128
    • McCully, K.1
  • 12
    • 0036963414 scopus 로고    scopus 로고
    • Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
    • 10.1191/1358863x02vm428ra 12553746
    • Keller C Hoffman U Loscalzo J Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine 2002, 7(3):227-239. 10.1191/1358863x02vm428ra 12553746
    • (2002) Vascular Medicine , vol.7 , Issue.3 , pp. 227-239
    • Keller, C.1    Hoffman, U.2    Loscalzo, J.3
  • 13
    • 28344446460 scopus 로고    scopus 로고
    • Mechanisms of homocysteine-induced atherothrombosis
    • 10.1111/j.1538-7836.2005.01364.x 16102030
    • Lentz S Mechanisms of homocysteine-induced atherothrombosis J Thromb Haemost 2005, 3(8):1646-54. 10.1111/j.1538-7836.2005.01364.x 16102030
    • (2005) J Thromb Haemost , vol.3 , Issue.8 , pp. 1646-1654
    • Lentz, S.1
  • 14
    • 51649112963 scopus 로고    scopus 로고
    • Murine models of hyperhomocysteinemia and their vascular phenotypes
    • 2574668 18556571 10.1161/ATVBAHA.108.166421
    • Dayal S Lentz S Murine models of hyperhomocysteinemia and their vascular phenotypes Arterioscler Thromb Vasc Biol 2008, 28(9):1596-605. 2574668 18556571 10.1161/ATVBAHA.108.166421
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , Issue.9 , pp. 1596-1605
    • Dayal, S.1    Lentz, S.2
  • 15
    • 0035107609 scopus 로고    scopus 로고
    • Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
    • 208940 11254667 10.1172/JCI10588
    • Hofmann M Lalla E Gleason M Kohl B Wolf B Kiesel W Stern D Schmidt A Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model J Clin Invest 2001, 107(6):675-83. 208940 11254667 10.1172/JCI10588
    • (2001) J Clin Invest , vol.107 , Issue.6 , pp. 675-683
    • Hofmann, M.1    Lalla, E.2    Gleason, M.3    Kohl, B.4    Wolf, B.5    Kiesel, W.6    Stern, D.7    Schmidt, A.8
  • 17
    • 27944476897 scopus 로고    scopus 로고
    • Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia
    • 10.1157/13079763 16238959
    • Fernandez C Yebra M Ribera C Toledo T Martin M Gomez P Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia Rev Clin Esp 2005, 205(10):489-92. 10.1157/13079763 16238959
    • (2005) Rev Clin Esp , vol.205 , Issue.10 , pp. 489-492
    • Fernandez, C.1    Yebra, M.2    Ribera, C.3    Toledo, T.4    Martin, M.5    Gomez, P.6
  • 19
    • 45749106731 scopus 로고    scopus 로고
    • Hyperhomocysteinemia due to pernicious anemia leading to pulmonary thromboembolism in a heterozygous mutation carrier
    • 10.1177/1076029607305101 18586684
    • Küpeli E Cengiz C Cila A Karnak D Hyperhomocysteinemia due to pernicious anemia leading to pulmonary thromboembolism in a heterozygous mutation carrier Clin Appl Thromb Hemost 2008, 14(3):365-8. 10.1177/ 1076029607305101 18586684
    • (2008) Clin Appl Thromb Hemost , vol.14 , Issue.3 , pp. 365-368
    • Küpeli, E.1    Cengiz, C.2    Cila, A.3    Karnak, D.4
  • 20
    • 0033812945 scopus 로고    scopus 로고
    • Genetic modulation of homocysteinemia
    • 10.1055/s-2000-8470 11011843
    • Rozen R Genetic modulation of homocysteinemia Semin Thromb Hemost 2000, 26:255-261. 10.1055/s-2000-8470 11011843
    • (2000) Semin Thromb Hemost , vol.26 , pp. 255-261
    • Rozen, R.1
  • 21
    • 38049152741 scopus 로고    scopus 로고
    • In vitamin b12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentration
    • 2148411 18056804 10.1073/pnas.0709487104
    • Selhub J Morris MS Jaques PF In vitamin b12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentration PNAS 2007, 104(50):19995-20000. 2148411 18056804 10.1073/pnas.0709487104
    • (2007) PNAS , vol.104 , Issue.50 , pp. 19995-20000
    • Selhub, J.1    Morris, M.S.2    Jaques, P.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.